BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Down 61.2% in January

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 48,200 shares, a drop of 61.2% from the December 31st total of 124,200 shares. Based on an average daily trading volume, of 365,000 shares, the short-interest ratio is presently 0.1 days.

BlackRock Health Sciences Term Trust Stock Down 0.7 %

NYSE BMEZ traded down $0.12 during trading hours on Wednesday, hitting $16.40. The company had a trading volume of 248,383 shares, compared to its average volume of 563,760. The firm’s 50 day moving average is $15.34 and its 200 day moving average is $15.62. BlackRock Health Sciences Term Trust has a fifty-two week low of $14.27 and a fifty-two week high of $16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 15th will be given a dividend of $0.1782 per share. This represents a $2.14 annualized dividend and a yield of 13.04%. The ex-dividend date is Wednesday, January 15th.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Brown Brothers Harriman & Co. acquired a new position in shares of BlackRock Health Sciences Term Trust in the third quarter worth about $32,000. K2 Principal Fund L.P. acquired a new stake in BlackRock Health Sciences Term Trust in the third quarter worth about $158,000. Jane Street Group LLC acquired a new position in shares of BlackRock Health Sciences Term Trust during the third quarter valued at approximately $357,000. Dakota Wealth Management increased its position in shares of BlackRock Health Sciences Term Trust by 23.4% during the 3rd quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the period. Finally, Kingswood Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the fourth quarter worth about $420,000.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.